NR1I3

Nuclear receptor subfamily 1 group I member 3 UniProt accession Q14994

Binds and transactivates the retinoic acid response elements that control expression of the retinoic acid receptor beta 2 and alcohol dehydrogenase 3 genes. Transactivates both the phenobarbital responsive element module of the human CYP2B6 gene and the CYP3A4 xenobiotic response element

Source: UniProt

Interacts with ECT2 (By similarity). Heterodimer of NR1I3 and RXR. Interacts with PSMC4.

Directly interacts with DNAJC7. The DNAJC7-NR1I3 complex may also include HSP90 (By similarity). Interacts with CRY1 (By similarity).

Interacts with CRY2 in a ligand-dependent manner (By similarity)

Source: UniProt
Nucleus, Cytoplasm, Cytoplasm, cytoskeleton
Source: UniProt

Predominantly expressed in liver

Source: UniProt

Composed by a short N-terminal domain followed by the DNA binding, hinge, and ligand binding/dimerization domains

Source: UniProt
  • Nuclear Receptor transcription pathway
Source: Reactome via UniProt

Mutations

No mutation information available.

Synthetic Lethal Network

Genes with an experimentally identified or computationally predicted synthetic-lethal relationship to NR1I3, aggregated across our SSL data sources. Click any partner node to view that gene’s page.

Nodes and edges are coloured by the SSL data source. Partners appearing in more than one source are shown in grey.

BioGRID SLOrth SynLethDB MexDrugs Multi-source
Sources: BioGRID, SLOrth, SynLethDB, MexDrugs

Clinical Trials

No clinical trials information available.